• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组织转谷氨酰胺酶的可逆性竞争性肉桂酰三唑抑制剂

Reversible and competitive cinnamoyl triazole inhibitors of tissue transglutaminase.

作者信息

Pardin Christophe, Roy Isabelle, Lubell William D, Keillor Jeffrey W

机构信息

Département de chimie, Université de Montréal, C.P. 6128, Succursale centre-ville, Montréal, QC H3C 3J7, Canada.

出版信息

Chem Biol Drug Des. 2008 Sep;72(3):189-96. doi: 10.1111/j.1747-0285.2008.00696.x. Epub 2008 Aug 19.

DOI:10.1111/j.1747-0285.2008.00696.x
PMID:18715232
Abstract

A series of 15 cinnamoyl triazole derivatives was prepared by Cu(I)-catalyzed azide/alkyne [3+2]-cycloaddition reactions and examined as inhibitors of guinea-pig liver transglutaminase. Several compounds exhibited activity as reversible inhibitors that were competitive with acyl donor transglutaminase substrates. For example, triazole 4d has a K(i) value of 174 nM and represents one of the most potent reversible transglutaminase inhibitors reported to date.

摘要

通过铜(I)催化的叠氮化物/炔烃[3 + 2]环加成反应制备了一系列15种肉桂酰基三唑衍生物,并将其作为豚鼠肝脏转谷氨酰胺酶的抑制剂进行了研究。几种化合物表现出作为可逆抑制剂的活性,它们与酰基供体转谷氨酰胺酶底物具有竞争性。例如,三唑4d的K(i)值为174 nM,是迄今为止报道的最有效的可逆转谷氨酰胺酶抑制剂之一。

相似文献

1
Reversible and competitive cinnamoyl triazole inhibitors of tissue transglutaminase.组织转谷氨酰胺酶的可逆性竞争性肉桂酰三唑抑制剂
Chem Biol Drug Des. 2008 Sep;72(3):189-96. doi: 10.1111/j.1747-0285.2008.00696.x. Epub 2008 Aug 19.
2
Cinnamoyl inhibitors of tissue transglutaminase.组织转谷氨酰胺酶的肉桂酰抑制剂
J Org Chem. 2008 Aug 1;73(15):5766-75. doi: 10.1021/jo8004843. Epub 2008 Jun 27.
3
Photolabeling of tissue transglutaminase reveals the binding mode of potent cinnamoyl inhibitors.组织转谷氨酰胺酶的光标记揭示了强效肉桂酰抑制剂的结合模式。
Biochemistry. 2009 Apr 21;48(15):3346-53. doi: 10.1021/bi802021c.
4
A potent and highly selective inhibitor of human alpha-1,3-fucosyltransferase via click chemistry.一种通过点击化学作用对人α-1,3-岩藻糖基转移酶具有强效且高度选择性的抑制剂。
J Am Chem Soc. 2003 Aug 13;125(32):9588-9. doi: 10.1021/ja0302836.
5
Toward analogues of MraY natural inhibitors: synthesis of 5'-triazole-substituted-aminoribosyl uridines through a Cu-catalyzed azide-alkyne cycloaddition.针对 MraY 天然抑制剂类似物的研究:通过铜催化的叠氮-炔环加成反应合成 5'-三唑取代-氨基核糖尿嘧啶。
J Org Chem. 2013 Oct 18;78(20):10088-105. doi: 10.1021/jo4014035. Epub 2013 Oct 7.
6
A sensitive fluorometric assay for tissue transglutaminase.一种用于组织转谷氨酰胺酶的灵敏荧光测定法。
Anal Biochem. 2001 May 15;292(2):198-206. doi: 10.1006/abio.2001.5040.
7
Ruthenium-catalyzed azide-alkyne cycloaddition: scope and mechanism.钌催化的叠氮化物-炔烃环加成反应:范围与机理
J Am Chem Soc. 2008 Jul 16;130(28):8923-30. doi: 10.1021/ja0749993. Epub 2008 Jun 21.
8
One-pot procedure for diazo transfer and azide-alkyne cycloaddition: triazole linkages from amines.重氮转移与叠氮-炔环加成的一锅法:由胺生成三唑连接键
Org Lett. 2007 Jan 4;9(1):1-4. doi: 10.1021/ol0621506.
9
Synthesis of novel steroidal 17α-triazolyl derivatives via Cu(I)-catalyzed azide-alkyne cycloaddition, and an evaluation of their cytotoxic activity in vitro.通过 Cu(I)-催化的叠氮-炔环加成反应合成新型甾体 17α-三唑基衍生物,并评估其体外细胞毒性活性。
Steroids. 2011 Sep-Oct;76(10-11):1141-8. doi: 10.1016/j.steroids.2011.05.002. Epub 2011 May 10.
10
Cu-catalyzed azide-alkyne cycloaddition.铜催化的叠氮化物-炔烃环加成反应
Chem Rev. 2008 Aug;108(8):2952-3015. doi: 10.1021/cr0783479.

引用本文的文献

1
On the Facile Synthesis of Triazaarsoles Using Acyclic Precursors.利用无环前体简便合成三氮杂砷茂
Chemistry. 2025 May 14;31(27):e202500514. doi: 10.1002/chem.202500514. Epub 2025 Apr 7.
2
Biological Implications and Functional Significance of Transglutaminase Type 2 in Nervous System Tumors.转谷氨酰胺酶 2 在神经系统肿瘤中的生物学意义和功能意义。
Cells. 2024 Apr 11;13(8):667. doi: 10.3390/cells13080667.
3
Pathogenetic Contributions and Therapeutic Implications of Transglutaminase 2 in Neurodegenerative Diseases.转谷氨酰胺酶 2 在神经退行性疾病中的发病机制贡献和治疗意义。
Int J Mol Sci. 2024 Feb 17;25(4):2364. doi: 10.3390/ijms25042364.
4
Targeting transglutaminase 2 mediated exostosin glycosyltransferase 1 signaling in liver cancer stem cells with acyclic retinoid.用无环维甲酸靶向肝癌干细胞中的转谷氨酰胺酶 2 介导的外生粘蛋白糖基转移酶 1 信号通路。
Cell Death Dis. 2023 Jun 13;14(6):358. doi: 10.1038/s41419-023-05847-4.
5
Computational investigations of click-derived 1,2,3-triazoles as keystone ligands for complexation with transition metals: a review.点击衍生的1,2,3-三唑作为与过渡金属络合的关键配体的计算研究:综述
RSC Adv. 2018 Mar 29;8(22):12232-12259. doi: 10.1039/c8ra00283e. eCollection 2018 Mar 26.
6
Exploring the Role of Transglutaminase in Patients with Glioblastoma: Current Perspectives.探索转谷氨酰胺酶在胶质母细胞瘤患者中的作用:当前观点
Onco Targets Ther. 2022 Mar 19;15:277-290. doi: 10.2147/OTT.S329262. eCollection 2022.
7
Development of new scaffolds as reversible tissue transglutaminase inhibitors, with improved potency or resistance to glutathione addition.开发新型支架作为可逆性组织转谷氨酰胺酶抑制剂,提高其效力或增强对添加谷胱甘肽的耐受性。
Medchemcomm. 2016 Dec 5;8(2):338-345. doi: 10.1039/c6md00565a. eCollection 2017 Feb 1.
8
Transamidase site-targeted agents alter the conformation of the transglutaminase cancer stem cell survival protein to reduce GTP binding activity and cancer stem cell survival.转酰胺酶位点靶向剂改变转谷氨酰胺酶癌症干细胞存活蛋白的构象,以降低GTP结合活性并减少癌症干细胞存活。
Oncogene. 2017 May 25;36(21):2981-2990. doi: 10.1038/onc.2016.452. Epub 2016 Dec 12.
9
Strategies towards in vivo imaging of active transglutaminase type 2 using positron emission tomography.利用正电子发射断层扫描对活性组织转谷氨酰胺酶2进行体内成像的策略。
Amino Acids. 2017 Mar;49(3):585-595. doi: 10.1007/s00726-016-2288-y. Epub 2016 Jul 5.
10
Synthesis and in Vitro Antiproliferative Evaluation of C-13 Epimers of Triazolyl-d-Secoestrone Alcohols: The First Potent 13α-d-Secoestrone Derivative.三唑基 - d - 去甲雌甾醇醇C - 13差向异构体的合成及体外抗增殖活性评价:首个强效13α - d - 去甲雌甾醇衍生物
Molecules. 2016 May 12;21(5):611. doi: 10.3390/molecules21050611.